Physician

Roma Srivastava, M.D.

According to 2025 Medicare claims, Roma Srivastava, M.D. (NPI: 1407102965) practices hematology/oncology in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Hamilton, OH. This provider's primary affiliated billing organization is ONCOLOGY HEMATOLOGY CARE INC (NPI: 1790778041; TIN: 311106418) and primary practice location at 45242-5621. Srivastava is affiliated with the Mercy Health Select, LLC (ACO ID: A1215), participating under the MSSP model.

Srivastava's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 445 traditional Medicare patients, billed 87,505 HCPCS/CPT codes, and received $1,866,582 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,062 prescription claims across 235 beneficiaries totaling $970,966 in drug costs, led by Verzenio (Abemaciclib). DME data shows 22 claims. Open Payments data shows 19 records totaling $4,158. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $11,441 to $1,866,582. Similarly, Part D prescription costs have moved sharply higher in recent years, from $4,858 to $970,966. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	44	112	$11,441
2019	153	434	$37,943
2020	199	515	$40,536
2021	257	723	$67,169
2022	520	35,833	$574,822
2023	479	92,279	$1,760,003
2024	445	87,505	$1,866,582

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	39	132	$4,858
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	14	72	$129,459
2019	64	215	$264,083
2020	74	349	$661,525
2021	155	852	$1,355,738
2022	261	817	$1,205,664
2023	249	1,152	$1,874,503
2024	235	1,062	$970,966

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	40	$3,266
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	22	$1,197

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	133	281	$89
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	222	308	$59
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	252	426	$11
80053	Blood test, comprehensive group of blood chemicals	155	317	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	198	508	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Verzenio	Abemaciclib	12	336	$184,792
Sprycel	Dasatinib	11	309	$104,041
Eliquis	Apixaban	37	1,590	$30,871
Xarelto	Rivaroxaban	27	1,567	$28,412
Letrozole	Letrozole	280	18,590	$5,074

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	11	$827
E1392	Portable oxygen concentrator, rental	Y	N/R	11	$369

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	16	$558	JAZZ PHARMACEUTICALS INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	3	$3,600	Tolmar, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Roma Srivastava, M.D.?

Tedicare shows public-source Medicare data for Roma Srivastava, M.D. (NPI 1407102965), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Roma Srivastava, M.D. have ACO affiliation data?

Roma Srivastava, M.D. is shown with ACO affiliation data for Mercy Health Select, LLC (MSSP, ACO ID A1215).

What billing organization is linked to Roma Srivastava, M.D.?

Roma Srivastava, M.D. is linked to ONCOLOGY HEMATOLOGY CARE INC (billing NPI 1790778041) in the available physician profile data.

Does Roma Srivastava, M.D. have Open Payments data?

Roma Srivastava, M.D. has 19 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.